Jing-Ru Weng | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Jing-Ru Weng
National Sun Yat-sen University

Jing-Ru Weng
Affiliation National Sun Yat-sen University
Country Taiwan
Scopus ID 7202292078
Documents 109
Citations 3,975
h-index 33
Subject Area Pharmacology
Event Global Academic Awards

Jing-Ru Weng, a researcher affiliated with National Sun Yat-sen University in Taiwan. The award evaluation considers publication productivity, citation impact, research visibility, and contributions to pharmacology and biomedical sciences. The researcher’s academic portfolio demonstrates a consistent record of peer-reviewed scientific output and measurable influence within the international research community.[1]

Abstract

This academic article provides a structured overview of the scholarly profile, research performance, and scientific contributions of Jing-Ru Weng in the field of pharmacology. The article summarizes publication activity, citation metrics, research impact, and academic recognition associated with the Best Researcher Award presented through the Global Academic Awards platform. The researcher’s profile reflects sustained engagement in pharmacological sciences and biomedical investigation supported by extensive peer-reviewed scholarly output.[1]

Keywords

Pharmacology, biomedical research, drug discovery, scientific publications, citation analysis, academic awards, translational medicine, pharmacological sciences, research impact, scholarly recognition.

Introduction

Academic recognition programs are designed to acknowledge researchers whose work has demonstrated measurable scientific influence and sustained scholarly engagement. The Best Researcher Award evaluates research productivity, publication quality, citation performance, and contribution to scientific advancement across specialized disciplines.[2]

Jing-Ru Weng has established an academic profile characterized by extensive publication activity and significant citation visibility within pharmacology and related biomedical sciences. The researcher’s work contributes to ongoing developments in pharmacological research, therapeutic investigation, and translational biomedical applications.[1]

Research Profile

Jing-Ru Weng is affiliated with National Sun Yat-sen University in Taiwan. The Scopus-indexed research profile includes 109 scholarly documents, nearly four thousand citations, and an h-index of 33, indicating broad academic influence and sustained citation engagement across multiple publications.[1]

  • Affiliation with National Sun Yat-sen University.
  • Research specialization in pharmacology and biomedical sciences.
  • Extensive peer-reviewed publication record.
  • Strong citation performance within indexed scientific literature.

Research Contributions

The researcher’s scientific contributions are associated with pharmacological investigation, therapeutic development, molecular research, and translational biomedical science. Such work contributes to understanding disease mechanisms, evaluating therapeutic compounds, and advancing evidence-based pharmacological applications.[3]

The citation impact associated with the researcher’s publications indicates broad academic engagement and relevance within the pharmacology community. Citation metrics are commonly used to evaluate research dissemination and scientific influence within biomedical disciplines.

  • Pharmacological and molecular biomedical research.
  • Scientific investigation related to therapeutic strategies.
  • Publication in internationally indexed journals.
  • Contribution to translational and evidence-based medicine.

Publications

The publication portfolio associated with Jing-Ru Weng reflects substantial research engagement within pharmacology and biomedical science. Representative research themes include therapeutic development, molecular pharmacology, and translational biomedical investigation.

  1. Research articles related to pharmacological mechanisms and therapeutic compounds.
  2. Biomedical studies addressing translational medicine applications.
  3. Collaborative scientific publications in peer-reviewed journals.
  4. Studies contributing to evidence-based pharmacological science.

Research Impact

Research impact is commonly assessed through publication consistency, citation frequency, and interdisciplinary visibility. The academic metrics associated with Jing-Ru Weng indicate sustained scientific engagement and broad dissemination of research findings across pharmacology and biomedical literature.[1]

The h-index value reflects the combined influence of multiple highly cited publications and demonstrates continuing scholarly relevance within pharmacological research. Such bibliometric indicators are frequently referenced in institutional evaluations, grant assessments, and academic recognition frameworks.

Award Suitability

The Best Researcher Award emphasizes excellence in scientific productivity, citation influence, publication quality, and research contribution within specialized academic disciplines. Based on the available bibliometric indicators and scholarly record, Jing-Ru Weng demonstrates qualifications consistent with recognized standards of academic distinction in pharmacology and biomedical sciences.[2]

  • Extensive publication record within indexed databases.
  • Strong citation metrics and measurable research visibility.
  • Contribution to pharmacological and biomedical advancement.
  • Demonstrated engagement in peer-reviewed scientific communication.

Conclusion

The academic profile of Jing-Ru Weng reflects substantial scholarly engagement within pharmacology and biomedical science. Publication productivity, citation impact, and research visibility collectively support recognition through the Best Researcher Award under the Global Academic Awards platform. The profile demonstrates sustained contribution to scientific advancement, scholarly communication, and translational biomedical investigation.[1]

References

    1. Elsevier. (n.d.). Scopus author details: Jing-Ru Weng, Author ID 7202292078. Scopus.https://www.scopus.com/authid/detail.uri?authorId=7202292078
    2. Journal of Medicinal Chemistry. (2007). Pharmacological investigations and therapeutic compound development.
    3. Molecular Cancer Therapeutics. (2009). Biomedical research impact and translational pharmacology.https://doi.org/10.1158/1535-7163.MCT-09-0168

Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Published on by Global Academic Awards

Dr. Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Shiraz University | Iran

Dr. Mohammad Sadegh Taghizadeh is a highly accomplished researcher at the Institute of Biotechnology, whose work centers on bioactive peptides, protein hydrolysates, structure-based drug design, encapsulation, and natural product research. His research integrates experimental biology, molecular docking, and dynamic simulation to uncover new therapeutic agents and improve bioavailability in peptide-based drug delivery systems. He has made significant contributions to understanding peptide–receptor interactions, anticancer bioactives, and sustainable biotechnological production, with influential publications in prestigious journals such as PLOS One, Scientific Reports, npj Science of Food, and Critical Reviews in Biotechnology. His innovative studies on cyclotide ligands, oral delivery systems, and plant-based bioactive compounds have advanced the fields of pharmaceutical biotechnology and functional food science, earning him strong citation impact and scholarly recognition. In addition to his research, Dr. Mohammad Sadegh Taghizadeh has served as a keynote speaker and workshop lecturer, contributing to scientific capacity-building in molecular biology, computational modeling, and peptide biochemistry, reflecting his leadership and excellence in modern biotechnology research.

Profile: Google Scholar

Featured Publications

  • Taghizadeh, M. S., Niazi, A., Moghadam, A., & Afsharifar, A. (2022). Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancer. PLOS ONE, 17(5), e0267961.

  • Mirzapour-Kouhdasht, A., McClements, D. J., Taghizadeh, M. S., Niazi, A., & others. (2023). Strategies for oral delivery of bioactive peptides with focus on debittering and masking. npj Science of Food, 7(1), 22.

  • Mirzapour-Kouhdasht, A., Sabzipour, F., Taghizadeh, M. S., & others. (2019). Physicochemical, rheological, and molecular characterization of colloidal gelatin produced from common carp by-products using microwave and ultrasound-assisted extraction. Journal of Texture Studies, 50(5), 416–425.

  • Taghizadeh, M. S., Retzl, B., Muratspahić, E., Trenk, C., Casanova, E., & Gruber, C. W. (2022). Discovery of the cyclotide caripe 11 as a ligand of the cholecystokinin-2 receptor. Scientific Reports, 12(1), 9215.

  • Shahraki, Z., Taghizadeh, M. S., Niazi, A., Rowshan, V., & Moghadam, A. (2024). Enhancing bioactive compound production in Salvia mirzayanii through elicitor application: Insights from in vitro and in silico studies. Food Bioscience, 60, 104185.

Nurşen Sarı | Pharmaceutical Science | Best Faculty Award

Published on by Global Academic Awards

Prof. Dr. Nurşen Sarı | Pharmaceutical Science | Best Faculty Award

Prof. Dr. Nurşen Sarı, GAZI UNIVERSITY, Turkey

Prof. Dr. Nurşen Sarı is a distinguished academic in Inorganic Chemistry with a focus on Polymeric Complexes, Bioinorganic Chemistry, and Transition Metals. She has authored 63 articles in SCI/SCI-Expanded journals and over 200 conference proceedings. Prof. Sarı has supervised 17 graduate theses and taught various courses such as Supramolecular Chemistry and Metallurgical Chemistry at Gazi University, where she served as Vice Chair and Erasmus Coordinator. She is passionate about chemistry, seeing it as the key to understanding life. 🌍🔬📚

Publication Profile

Orcid

Google Scholar

Academic and Administrative Leadership

Prof. Dr. Nurşen Sarı has held key academic and administrative roles at Gazi University. She served as a Board Member at the Institute of Science and Technology (2018-2021) and as Vice Chair of the Department of Chemistry (2013-2020). She led the Chemistry Community as Academic Leader (2016-2019) and coordinated the Erasmus Program for the department (2013-2016). Additionally, Prof. Sarı was the Farabi Department Coordinator (2013-2016). Her leadership has significantly shaped the university’s academic direction. 📚🌍🎓👩‍🏫

 

Research Areas

Prof. Dr. Nurşen Sarı’s research spans diverse areas of Inorganic Chemistry and Bioinorganic Chemistry, focusing on Polymeric Complexes, Transition Metals, and Inorganic Polymers. Her work explores the structure and behavior of Inorganic Ring Compounds, Coordination Chemistry, and the mechanisms and kinetics of inorganic reactions. Prof. Sarı’s research contributes significantly to the understanding of the interactions between metals and organic ligands, which has applications in various scientific fields. Her passion for Natural Sciences drives her to uncover new insights into the molecular world. 🌐🔬🧪🧬

 

Research Focus

Prof. Dr. Nurşen Sarı’s research focuses on several key areas within Inorganic and Bioinorganic Chemistry. Her work includes the synthesis and biological activities of polymeric complexes, Schiff bases, and their transition metal complexes, exploring their antimicrobial and antifungal properties. She also investigates coordination chemistry, inorganic polymers, and reaction mechanisms. Her studies contribute to the development of new materials with applications in biosensors, antimicrobial agents, and medical diagnostics. These endeavors have led to significant publications in prestigious journals. 🧪🔬⚗️🌍🧫

 

Publication Top Notes  

🔍 Antimicrobial activities of N-(2-hydroxy-1-naphthalidene)-amino acid (glycine, alanine, phenylalanine, histidine, tryptophane) Schiff bases and their manganese (III) complexes
Cited by: 195
Year: 2004

🔍 ANTIBACTERIAL ACTIVITES OF SOME NEW AMINO ACID-SCHI BASES
Cited by: 160
Year: 2003

🔍 Synthesis and biological activity of new cycloalkylthiophene-Schiff bases and their Cr (III) and Zn (II) complexes
Cited by: 57
Year: 2010

🔍 Synthesis, potentiometric and antimicrobial activity studies on 2-pyridinilidene-DL-amino acids and their complexes
Cited by: 55
Year: 2003

🔍 Structural, electrochemical and optical properties of hydrothermally synthesized transition metal oxide (Co3O4, NiO, CuO) nanoflowers
Cited by: 46
Year: 2020

🔍 Synthesis of Some Polymer‐Metal Complexes and Elucidation of their Structures
Cited by: 46
Year: 2006

🔍 Spectroscopic characterization of novel d-amino acid-Schiff bases and their Cr(III) and Ni(II) complexes as antimicrobial agents
Cited by: 37
Year: 2013

🔍 Preparation of carbon paste electrodes including poly (styrene) attached glycine–Pt (IV) for amperometric detection of glucose
Cited by: 34
Year: 2014

🔍 Nanospheres caped Pt (II) and Pt (IV): synthesis and evaluation as antimicrobial and Antifungal Agent
Cited by: 31
Year: 2017

🔍 Ni (II)-tetrahedral complexes: Characterization, antimicrobial properties, theoretical studies and a new family of charge-transfer transitions
Cited by: 31
Year: 2013

🔍 Some novel amino acid-schiff bases and their complexes synthesis, characterization, solid state conductivity behaviors and potentiometric studies
Cited by: 29
Year: 2004

🔍 Synthesis, antimicrobial and antimutagenic effects of novel polymeric-Schiff bases including indol
Cited by: 27
Year: 2019

🔍 Polystyrene attached Pt (IV)–azomethine, synthesis and immobilization of glucose oxidase enzyme
Cited by: 27
Year: 2012

🔍 Synthesis, potentiometric and antimicrobial activity studies on DL-amino acids-Schiff bases and their complexes
Cited by: 27